People · Operator

Stanley M. Goldstein

Named in public records as an officer, director or promoter · active 2010–2014 · Other Health Care

1
Companies
4
Filings
$3.5M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Vermedx Inc.Other Health CarePre-Seed$3.5M$7.7M2010
Operator network

Stanley M. Goldstein at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Lee Bouyea · 5 companies · 1 sharedLee BouyeaStanley Goldstein · 3 companies · 1 sharedStanley GoldsteinDavid Potter · 2 companies · 1 sharedDavid PotterMichael Gagnon · 2 companies · 1 sharedMichael GagnonReginald Gignoux · 2 companies · 1 sharedReginald GignouxBenjamin Littenberg · 1 companies · 1 sharedBenjamin Littenbe…Benjamin M. Littenberg · 1 companies · 1 sharedBenjamin M. Litte…Charles MacLean · 1 companies · 1 sharedCharles MacLeanHenry M. Tufo · 1 companies · 1 sharedHenry M. TufoHenry Tufo · 1 companies · 1 sharedHenry TufoLee M. Bouyea · 1 companies · 1 sharedLee M. BouyeaMichael MacCaskey · 1 companies · 1 sharedMichael MacCaskeyMichael M. MacCaskey · 1 companies · 1 sharedMichael M. MacCas…Richard Elmore · 1 companies · 1 sharedRichard ElmoreVermedx Inc. · $3.5M raisedVermedx Inc.Stanley M. GoldsteinSG
Stanley M. Goldstein Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Stanley M. Goldstein on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Lee Bouyea15
Stanley Goldstein13
David Potter12
Michael Gagnon12
Reginald Gignoux12
Benjamin M. Littenberg11
Lee M. Bouyea11
Michael M. MacCaskey11
Henry M. Tufo11
Michael MacCaskey11
Henry Tufo11
Richard Elmore11
Charles MacLean11
Benjamin Littenberg11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.